"Powerful" new treatments for various types of cancer and neurodegenerative disorders, such as Alzheimer's, Parkinson's, and ...

An announcement from Pharmaust Limited ( ($AU:NUZ) ) is now available. Neurizon Therapeutics Limited announced the results of its Annual General ...

Learn about Amyotrophic Lateral Sclerosis (ALS), its symptoms, risk factors, diagnosis, and current research advancements.

Eric Dane’s latest role is probably his most personal to date. The “Euphoria” star has been talking about his diagnosis with ...

The "Euphoria" actor guest stars as a firefighter living with the emotional and physical struggles of ALS in an episode of ...

The Hoffman ALS Clinical Trial Awards Program was created to fund early- to mid-stage biomarker-driven clinical trials of novel or repurposed therapeutics for ALS -- MIAMI, Nov. 25, 2025 (GLOBE ...

The medical drama’s showrunner, Michael Grassi, said the experience of making the episode with Dane would impact him for the ...

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing ...

Aperture will advance APRTX-001 as a potential treatment for ALS and frontotemporal dementia, with possible expansion for use ...

Recent developments in health include the FDA's new focus on expedited drug approvals, potential ALS treatment breakthroughs ...

Researchers at the University of Toronto's Temerty Faculty of Medicine have found widespread genetic and protein changes in ...

A Winnipeg scientist developing a new drug candidate for Amyotrophic Lateral Sclerosis has been awarded a national Mitacs ...